These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
205 related items for PubMed ID: 11077467
1. Glyburide/metformin (Glucovance) for type 2 diabetes. Med Lett Drugs Ther; 2000 Nov 13; 42(1092):105-6. PubMed ID: 11077467 [No Abstract] [Full Text] [Related]
3. Transitioning patients with type 2 diabetes to a fixed combination > glyburide/metformin tablet. Blonde L, Sandberg MI. Diabetes Technol Ther; 2000 Nov 13; 2(3):479-80. PubMed ID: 11467351 [No Abstract] [Full Text] [Related]
4. Metformin plus glyburide combination as initial therapy in type 2 diabetes: one month follow-up. Medina Santillán R, Reyes-García G, Mateos-García E. Proc West Pharmacol Soc; 2002 Nov 13; 45():137-8. PubMed ID: 12434558 [No Abstract] [Full Text] [Related]
11. An open, randomized, parallel-group study to compare the efficacy and safety profile of inhaled human insulin (Exubera) with glibenclamide as adjunctive therapy in patients with type 2 diabetes poorly controlled on metformin: response to Barnett et al. Kanna B, Abreu-Pacheco H. Diabetes Care; 2007 Feb 30; 30(2):445-6; author reply 446. PubMed ID: 17259531 [No Abstract] [Full Text] [Related]
12. Patient characteristics not described. Lofsky S. CMAJ; 2006 Jun 20; 174(13):1874. PubMed ID: 16785468 [No Abstract] [Full Text] [Related]
14. Cardiovascular, metabolic and hormonal responses to the progressive exercise performed to exhaustion in patients with type 2 diabetes treated with metformin or glyburide. Cunha MR, Silva ME, Machado HA, Fukui RT, Correia MR, Santos RF, Wajchenberg BL, Rocha DM, Rondon MU, Negrão CE, Ursich MJ. Diabetes Obes Metab; 2008 Mar 20; 10(3):238-45. PubMed ID: 18269639 [Abstract] [Full Text] [Related]
15. Unsurpassed glycaemic control made simple. Cardiovasc J S Afr; 2003 Mar 20; 14(5):288. PubMed ID: 14664235 [No Abstract] [Full Text] [Related]
16. [Formulation by design of experiments of immediate release tablets with metformin hydrochloride and glibenclamide]. Potur RG, Gafiţanu E. Rev Med Chir Soc Med Nat Iasi; 2010 Mar 20; 114(4):1219-26. PubMed ID: 21500483 [Abstract] [Full Text] [Related]
17. Metaglip and Avandamet for type 2 diabetes. Med Lett Drugs Ther; 2002 Dec 23; 44(1146):107-9. PubMed ID: 12500153 [No Abstract] [Full Text] [Related]
18. The effect of pioglitazone as add-on therapy to metformin or sulphonylurea compared to a fixed-dose combination of metformin and glibenclamide on diabetic dyslipidaemia. Comaschi M, Corsi A, Di Pietro C, Bellatreccia A, Mariz S, COM06 Study Investigators. Nutr Metab Cardiovasc Dis; 2008 Jun 23; 18(5):373-9. PubMed ID: 17919894 [Abstract] [Full Text] [Related]
19. The development of an oral antidiabetic combination tablet: design, evaluation and clinical benefits for patients with type 2 diabetes. Howlett H, Porte F, Allavoine T, Kuhn T, Nicholson G. Curr Med Res Opin; 2003 Jun 23; 19(3):218-25. PubMed ID: 12803736 [Abstract] [Full Text] [Related]
20. [Aspects of antihyperglycemic oral bitherapy in 76 cases of non insulindependent diabetes in Dakar]. Sidibé EH, Badiane MK, Gueye A. Sante; 2002 Jun 23; 12(3):319-22. PubMed ID: 12473527 [Abstract] [Full Text] [Related] Page: [Next] [New Search]